中间释放的动力学增强P450 11B2-催化阿尔多的合成
Juan Valentín-Goyco1,2,3, Sang-Choul Im1,2,3, Richard J Auchus1,2,3
1Division of Metabolism, Endocrinology, & Diabetes, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan 48109, United States.
Biochemistry
|April 2, 2024
概括
细胞染色体P450 11B2 (阿尔多合成酶) 通过一个过程机制合成阿尔多. 中间解离速率,而不是NADPH合,决定了阿尔多的产生,揭示了对类固醇生物合成的关键见解.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 酶学 是一种酶学.
背景情况:
- 细胞染色体P450 11B2 (阿尔多合成酶) 合成阿尔多,而P450 11B1 (11β-基酶) 合成皮质醇.
- 尽管P450 11B2具有高序列相同性,但它表现出独特的18-氧化活性和在P450 11B1中没有发现的过程性.
研究的目的:
- 阐明使P450 11B2独特的阿尔多素合成机制成为可能的生物化学和生物物理性质.
- 调查残留物320在区分P450 11B1和P450 11B2活动中的作用.
主要方法:
- 在P450 11B1和P450 11B2.2.中的残留物320 (V320A和A320V) 的位点定向突变发生.
- 脂囊泡和纳米盘中的野生类型和突变酶的净化和动态分析.
- 测量NADPH合效率,结合动力学,亲缘关系和产品形成.
主要成果:
- 阿尔多的合成与皮质分离率相反相关,而不是NADPH合效率.
- 在残留物320的突变中,在P450 11B1和P450 11B2.2.之间部分交换了酶活性.
- 动力学数据表明,P450 11B酶中的11-脱氧皮质 (DOC) 具有两步结合机制,有利于诱导适应.
结论:
- 中间解离动力学,而不是合效率,对于P450 11B2的过程性阿尔多素合成至关重要.
- 残留物320在区分P450 11B1和P450 11B2.2.活动方面发挥着作用.
- 这些发现为阿尔多激素生物合成和P450酶功能提供了机械洞察力.
相关概念视频
Drug Metabolism: Phase I Reactions
3.3K
A phase I reaction is a biochemical process that introduces a functionally reactive polar group to a substance. This transformation predominantly occurs in the liver, facilitated by the cytochrome P450 system of hemoproteins situated in the lipophilic endoplasmic reticulum of cells. The metabolite generated through this process can have varying polarities. If it is sufficiently polar, it can be easily excreted in the urine due to its water compatibility. However, if the metabolite is nonpolar,...
3.3K
Drug Metabolism: Phase II Reactions
3.8K
Phase II reactions are essential for the detoxification and elimination of drugs from the body. These reactions involve the conjugation of parent drugs or their phase I metabolites with endogenous molecules, resulting in more hydrophilic drug conjugates. The primary conjugation reactions in this phase are sulfation and glucuronidation. Both sulfation and glucuronidation typically produce biologically inactive metabolites. However, in some cases involving prodrugs, active metabolites may be...
3.8K
Base-Catalyzed Aldol Addition Reaction
3.3K
As depicted in Figure 1, base-catalyzed aldol addition involves adding two carbonyl compounds in aqueous sodium hydroxide to form a β-hydroxy carbonyl compound.
3.3K
Phase II Reactions: Sulfation and Conjugation with α-Amino Acids
224
Sulfation and α-amino acid conjugation are two critical biotransformation reactions in drug metabolism. Sulfation, a phase II biotransformation reaction, involves adding a polar sulfate group to a drug, enhancing its water solubility and promoting excretion. This process can either co-occur with or occur independently of glucuronidation. Nonmicrosomal sulfotransferase enzymes catalyze the process. The reaction involves 3'-phosphoadenosine-5'-phosphosulfate or PAPS coenzyme...
224
Renal Drug Excretion: Tubular Secretion
180
Active tubular secretion is a robust, energy-demanding process that utilizes carrier systems to transport drugs into renal tubules. The active renal secretion systems include the organic anion transporter (OAT) for weak acids and the organic cation transporter (OCT) for weak bases. Structurally similar drugs can compete for the same transporter, potentially leading to drug accumulation and toxicity. However, this principle can be exploited therapeutically. One example is probenecid (Probalan),...
180
Antihypertensive Drugs: Direct Renin Inhibitors
616
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
616


![Technical Aspect of the Automated Synthesis and Real-Time Kinetic Evaluation of [11C]SNAP-7941](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F59557.jpg&w=3840&q=50)